Exercise News and Research

Latest Exercise News and Research

FDA approves sNDA for pediatric autism drug ABILIFY

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.

20 Nov 2009

GOT YOUR BACK launches The Spinalis Chair

GOT YOUR BACK will be hosting an Open House at their retail location at 521 East Hector Street, Conshohocken, PA on December 12th from 1:00 p.m. - 4:00 p.m. Guests will include health and wellness professionals, chiropractors, massage therapists and those interested in alternative fitness and wellness throughout the tri-state area. Visitors will enjoy food, beverages, a free chair massage, and free on site diagnosis of the spine. This event is also open to the public and special discounts will be offered throughout the store exclusively for attendees of this event.

20 Nov 2009

Pfizer’s Revatio Injection receives FDA approval

Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.

20 Nov 2009

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18.

20 Nov 2009

Global initiative battles online supply of dangerous and illegal medicines

In response to an ever-increasing number of websites supplying dangerous and illegal medicines, Operation Pangea II, involving 24 countries, was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight the dangers of buying medicines online.

20 Nov 2009

High blood pressure: A major risk factor for stroke and heart disease

Today, Jamieson Laboratories, in partnership with the Victorian Order of Nurses (VON), is holding a one day Blood Pressure Blitz in Toronto's underground PATH system in an effort to educate consumers about the number one risk factor for stroke and a major risk factor of heart disease.

20 Nov 2009

Scientists find how 4-HB is metabolized by the body

It's a naturally occurring brain chemical with an unwieldy name: 4-hydroxybutyrate (4-HB). Taken by mouth, it can be abused or used as a date-rape drug.

20 Nov 2009

Maja Mataric' to evaluate robots as exercise coaches for adults of all ages

Maja Mataric', who directs the University of Southern California Center for Robotics and Embedded Systems, will lead an effort to evaluate robots as exercise coaches for adults of all ages, with a particular focus on the elderly.

20 Nov 2009

EMSC announces pricing of public secondary offering by affiliates of Onex Corporation

Emergency Medical Services Corporation today announced that certain of its equity holders, primarily affiliates of Onex Corporation, have priced a public secondary offering of 8,000,000 shares (increased from 6,000,000) of class A common stock at $48.31 per share.

20 Nov 2009

NIMS’ Exer-Rest acceleration therapeutic platform awarded Japanese patent

Non-Invasive Monitoring Systems, Inc. announced that the Nogawa Patent Office in Japan issued Patent number 4391595 to NIMS on October 16, 2009. This patent, entitled “Reciprocating Movement Platform for Shifting Subject To and Fro In Headwards-Footwards Direction,” relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

19 Nov 2009

Workshop to address cultural diversity and ethnicity in healthcare

International academics are to gather at the University of Leicester to discuss 'Civil Society and the Governance of Health Care' in a one-day workshop event sponsored by the Cinefogo European Network of Excellence and organised by Professor Carlo Ruzza and Dr Ellen Annandale from the Department of Sociology on Friday 20 November.

19 Nov 2009

Treatment of iron deficiency can improve symptoms and quality of life in CHF patients

Intravenous (I.V.) iron treatment with ferric carboxymaltose to reverse iron deficiency can significantly improve symptoms, exercise tolerance and quality of life for chronic heart failure (CHF) patients, researchers said in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

19 Nov 2009

UNGASS monitoring system provides the overall progress in the global response to HIV

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic. An update on the development of the UN General Assembly Special Session on HIV/AIDS (UNGASS) global reporting system appears in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes.

19 Nov 2009

Fully functional converged platform to provide a competitive edge in the European Security Convergence market

In Europe, the security credential convergence market is driven by the use of smart cards for both physical and logical access, video content analysis for the automation of emergency procedures, and by the integration of building management systems with security systems.

19 Nov 2009

HTHH and Soles4Souls team up to provide athletic shoes for Tennessee children

Hope Through Healing Hands (HTHH), a nonprofit founded by former Senator Bill Frist, M.D., has announced a partnership with Nashville-based Soles4Souls to benefit over 100,000 Tennessee children who are in need of a good pair of athletic shoes.

19 Nov 2009

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking.

19 Nov 2009

Sildenafil drug improves cardiac performance in young adults with congenital heart disease

Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.

19 Nov 2009

Tips for staying safe and healthy during Thanksgiving holiday

Visiting is a big part of the Thanksgiving holiday. But one place you don't want to stop by is the Emergency Department.

19 Nov 2009

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Clinical Data, Inc. today announced that it has enrolled the first patient in its initial Phase III trial of Stedivaze™, a potential best-in-class vasodilator for use in cardiac stress testing. The study will evaluate the safety and efficacy of Stedivaze (apadenoson) for use as a pharmacologic stress agent in myocardial perfusion imaging (MPI), a method for detecting defects in the blood supply to the heart.

18 Nov 2009

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.

18 Nov 2009

Exercise News and Research

Latest Exercise News and Research

FDA approves sNDA for pediatric autism drug ABILIFY

GOT YOUR BACK launches The Spinalis Chair

Pfizer’s Revatio Injection receives FDA approval

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

Global initiative battles online supply of dangerous and illegal medicines

High blood pressure: A major risk factor for stroke and heart disease

Scientists find how 4-HB is metabolized by the body

Maja Mataric' to evaluate robots as exercise coaches for adults of all ages

EMSC announces pricing of public secondary offering by affiliates of Onex Corporation

NIMS’ Exer-Rest acceleration therapeutic platform awarded Japanese patent

Workshop to address cultural diversity and ethnicity in healthcare

Treatment of iron deficiency can improve symptoms and quality of life in CHF patients

UNGASS monitoring system provides the overall progress in the global response to HIV

Fully functional converged platform to provide a competitive edge in the European Security Convergence market

HTHH and Soles4Souls team up to provide athletic shoes for Tennessee children

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Sildenafil drug improves cardiac performance in young adults with congenital heart disease

Tips for staying safe and healthy during Thanksgiving holiday

Clinical Data commences patient enrollment in Stedivaze Phase III trial

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Exercise News and Research

Latest Exercise News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in